// 本月早些時候，總部位於北京的國有企業中國銀行通過其在香港的投資部門，在以太坊上發行了2800萬美元的債券。此舉使得政府能夠利用開放的區塊鏈網絡來達成自己的目的，同時並不放棄對普通市民金融活動的控制權。

根據香港獨立記者Colin Wu的報導，今早香港最大的銀行滙豐已開始為客戶提供比特幣和以太坊ETF的投資途徑。目前該銀行的代表尚未對該報導發表評論。 https://www.politico.com/newsletters/digital-future-daily/2023/06/26/chinas-move-to-control-the-blockchain-00103710 //

// Insilico Medicine saw its revenue jump more than six times to $30.1 million in 2022 from the previous year, according to the filing. The company generates revenue from research and development collaborations with pharmaceutical companies and subscription fees for its generative AI platforms.

根據文件顯示，Insilico Medicine在2022年的收入從前一年的水平增長了超過六倍，達到了3010萬美元。該公司的收入來自於與制藥公司的研發合作以及其生成式人工智能平台的訂閱費用。 https://www.forbes.com/sites/zinnialee/2023/06/29/qiming-backed-ai-drug-discovery-startup-insilico-medicine-files-for-hong-kong-ipo/ //

// OneDegree Group co-founder and CEO Alvin Kwock remarked, “We have successfully achieved product market fit, which is testament to the team’s relentless focus on delivering customer-centric products… It is a real seal of approval to receive such strong backing from the market during this challenging fundraising environment. We’re delighted to welcome new investors and strategic partners in this latest closing, alongside our three largest existing institutional investors who also participated.” https://fintech.global/2023/06/29/digital-asset-insurtech-leader-onedegree-group-raises-55m-in-series-b/?utm_source=rss&utm_medium=rss&utm_campaign=digital-asset-insurtech-leader-onedegree-group-raises-55m-in-series-b //

// As part of the partnership, Mitsui will make an undisclosed investment in Hong Kong-based Animoca Brands. Mitsui, a unit of Japanese conglomerate Mitsui Group, and Animoca Brands aim to develop new businesses to facilitate the uptake of Web3 in the Japanese market.

作為合作的一部分，三井將對位於香港的Animoca Brands進行未公開的投資。三井是日本綜合集團三井集團的一部分，三井與Animoca Brands旨在開展新業務，促進日本市場對Web3的接受。 https://www.techinasia.com/animoca-partners-mitsui-web3-business-japan //

// Based in the Southeast Chinese city of Hangzhou, Adicon and its controlled entities operate 24 fully-owned diagnostic laboratories in China, offering diagnostic testing outsourcing services to more than 10,000 active customers in 28 provinces.

位於中國杭州市的艾迪康及其控股實體在中國運營著24個全資擁有的診斷實驗室，向28個省份的逾10,000名活躍客戶提供診斷測試外包服務。 https://www.channelnewsasia.com/business/chinese-diagnostic-lab-adicon-raise-52-million-global-offering-3571131 //

// 香港大學李嘉誠醫學院的研究團隊最近開發了一款新型測試平台，聲稱可同時試驗及改造數以百計鹼基編輯器，加快篩選基因編輯工具。相關研究由港大醫學院生物醫學學院副教授黃兆麟，率領博士生方凱俊及兩位博士後研發員進行

The research team at the Li Ka Shing Faculty of Medicine, The University of Hong Kong, has recently developed a new testing platform that claims to simultaneously test and modify hundreds of base editors, accelerating the screening of gene editing tools. The research is conducted by Associate Professor Wong Siu-lun from the School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, along with PhD student Fang Kaijun and two postdoctoral fellows. http://ejtech.hkej.com/?p=135199 //

// 百度於周五表示，已獲得監管機構頒發的商業許可證，以在深圳部分地區開展無人駕駛叫車服務。

China’s tech firm Baidu Inc said on Friday that it has obtained a commercial licence from regulators for its driverless ride-hailing service in parts of Shenzhen, the country’s tech hub. https://finance.yahoo.com/news/baidu-wins-licence-operate-driverless-082609402.html //

// ICCOV埃斯克福核酸疫苗是一種預防新冠病毒去氧核醣核酸（DNA）疫苗，是醫克生物旗下PD-1增強型DNA疫苗平台首款進入第二期臨床試驗的疫苗產品。PD-1增強型DNA疫苗平台由港大愛滋病研究所發明，並向醫克生物授予專利，用以研發針對癌症及傳染病的疫苗

ICCOV, developed by EscoVale, is a DNA vaccine designed to prevent the novel coronavirus (COVID-19). It is the first vaccine product from the PD-1 Enhanced DNA Vaccine Platform, a platform developed by EscoVale’s subsidiary, Biokine. The PD-1 Enhanced DNA Vaccine Platform was invented by the AIDS Institute at the University of Hong Kong and patented by EscoVale for the development of vaccines targeting cancer and infectious diseases. http://ejtech.hkej.com/?p=135269 //

// 創新科技獎學金由創新科技署、滙豐及香港青年協會於2011年攜手設立，每年向25名正修讀理學、工程、科技相關學科，以至醫科或醫療學科的本地大學傑出本科生，各頒發15萬元獎學金，獲獎者須為香港永久性居民

The Innovation and Technology Scholarship Award (ITSA) was jointly established by the Innovation and Technology Commission, HSBC, and the Hong Kong Federation of Youth Groups in 2011. It is awarded annually to 25 outstanding undergraduate students studying science, engineering, technology, medical, or healthcare-related disciplines in local universities. Each recipient receives a scholarship of HKD 150,000. Eligible awardees must be permanent residents of Hong Kong. http://startupbeat.hkej.com/?p=134967 //